Stock Snapshot from
Sucampo Pharmaceuticals IncAdd to My Watchlist
SCMP:USNASDAQ GMIndustry: Medical-Drugs
- 8.95Last
- 0.55 -5.79%Today's Change
- 9.50Previous Close
- 52 Week Low - High
Earnings
| EPS: Year Actual ttm | 0.080 |
| EPS: Year Est. 12/13 ttm | 0.056 |
| EPS: Quarterly Actual 3/13 | -0.08 |
| EPS: Quarterly Est. 6/13 | 0.18 |
| Price/Earnings ttm | 111.88 |
| Relative Price/Earnings | 6.862 |
| Earnings Growth Rate | -- |
Company Description
| Sucampo Pharmaceuticals, Inc. researches and develops drugs based on protones, which are derived from functional fatty acids. The Company produces a prescription drug for the treatment of chronic idiopathic constipation. | |
| Revenue | $81 million |
| Net Income | $5 million |
| Total Assets | $128 million |
| Employees | 128 |
| Web Site | www.sucampo.com |
Latest Headlines
Watchlist
Unless indicated otherwise: intraday data is at least 15 minutes delayed; mutual fund NAVs are updated at the close of every market day; all prices are in the local currency; Time is ET.